Advertisement
Screener

QUAKER CHEMICAL CORPORATION (KWR) Payments for Restructuring

2.8 / 5 stars · 68/120 Roast Me

QUAKER CHEMICAL CORPORATION Payments for Restructuring

QUAKER CHEMICAL CORPORATION (KWR) reported Payments for Restructuring of $11.34 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsForRestructuring · last filed 2026-07-30

  • QUAKER CHEMICAL CORPORATION payments for restructuring for the quarter ending 2026-06-30 was $7.46M.
  • QUAKER CHEMICAL CORPORATION payments for restructuring for the quarter ending 2026-03-31 was $3.88M.
  • QUAKER CHEMICAL CORPORATION payments for restructuring for the quarter ending 2022-03-31 was $408.00K, a 86.55% decline year-over-year.
  • QUAKER CHEMICAL CORPORATION payments for restructuring for the quarter ending 2021-03-31 was $3.03M, a 37.33% decline year-over-year.
  • QUAKER CHEMICAL CORPORATION payments for restructuring for fiscal 2017 was $675.00K, a 87.15% decline from fiscal 2016.
  • QUAKER CHEMICAL CORPORATION payments for restructuring for fiscal 2016 was $5.25M, a 971.84% increase from fiscal 2015.
  • QUAKER CHEMICAL CORPORATION payments for restructuring for fiscal 2015 was $490.00K.
Period endPayments for Restructuring 3 monthPayments for Restructuring 6 monthPayments for Restructuring 9 monthPayments for Restructuring 12 monthPayments for Restructuring 12 month as first filed
2026-06-30$7.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$11.34M
10-Q · filed 2026-07-30
2026-03-31$3.88M
10-Q · filed 2026-04-30
2022-03-31$408.00K
10-Q · filed 2022-05-05
2021-03-31$3.03M
10-Q · filed 2021-05-06
2020-03-31$4.84M
10-Q · filed 2020-05-11
2019-09-30-$4.64M
10-Q · filed 2019-11-12
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$0.00
derived: sum of 2 quarters · filed 2019-02-28
$527.00K
derived: sum of 3 quarters · filed 2019-02-28
$675.00K
10-K · filed 2019-02-28
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$527.00K
derived: sum of 2 quarters · filed 2018-11-01
$675.00K
10-Q · filed 2018-11-01
$1.73M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$527.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30
$675.00K
10-Q · filed 2018-07-30
$1.73M
derived: sum of 3 quarters · filed 2019-02-28
$3.60M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$148.00K
10-Q · filed 2018-04-30
$1.21M
derived: sum of 2 quarters · filed 2019-02-28
$3.07M
derived: sum of 3 quarters · filed 2019-02-28
$4.89M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$2.92M
derived: sum of 2 quarters · filed 2019-02-28
$4.74M
derived: sum of 3 quarters · filed 2019-02-28
$5.25M
10-K · filed 2019-02-28
2016-09-30$1.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26
$3.69M
derived: sum of 2 quarters · filed 2016-10-26
$4.19M
10-Q · filed 2016-10-26
2016-06-30$1.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27
$2.33M
10-Q · filed 2016-07-27
2016-03-31$509.00K
10-Q · filed 2016-04-27
2015-12-31$490.00K
10-K · filed 2018-02-28
-$490.00K
10-K · filed 2016-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
VALVOLINE INC (VVV)United States$3.618B49.71